Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$58.92 - $84.67 $4.74 Million - $6.82 Million
-80,526 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $6.96 Million - $8.84 Million
80,526 New
80,526 $8.47 Million
Q4 2021

Feb 14, 2022

SELL
$98.56 - $119.91 $6.93 Million - $8.43 Million
-70,296 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$86.24 - $95.92 $15,609 - $17,361
-181 Reduced 0.26%
70,296 $6.58 Million
Q1 2021

May 17, 2021

SELL
$71.83 - $95.48 $854,274 - $1.14 Million
-11,893 Reduced 14.44%
70,477 $6.49 Million
Q4 2020

Feb 16, 2021

BUY
$67.0 - $84.39 $5.52 Million - $6.95 Million
82,370 New
82,370 $6.03 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.